|
Update - Proposed issue of securities - OIL
|
26 June 2023 at 11:40am
|
|
Entitlement Offer Extension to Closing Date
|
26 June 2023 at 11:40am
|
|
Entitlement Offer - Letter to Ineligible Shareholders
|
7 June 2023 at 12:05pm
|
|
Entitlement Offer documents despatched to Shareholders
|
7 June 2023 at 12:00pm
|
|
Notification of cessation of securities - OIL
|
7 June 2023 at 9:30am
|
|
Section 708A Cleansing Notice
|
7 June 2023 at 8:55am
|
|
Application for quotation of securities - OIL
|
7 June 2023 at 8:50am
|
|
Entitlement Offer Timetable Update
|
30 May 2023 at 6:10pm
|
|
Proposed issue of securities - OIL
|
30 May 2023 at 10:25am
|
|
Optiscan Entitlement Issue Prospectus
|
30 May 2023 at 10:25am
|
|
Optiscan Launches Entitlement Offer to Raise $16.7M
|
30 May 2023 at 10:20am
|
|
Trading Halt
|
26 May 2023 at 9:55am
|
|
Optiscan Oral Study Published in Prestigious Medical Journal
|
15 May 2023 at 9:30am
|
|
OIL March 2023 Quarterly Report and Appendix 4C
|
28 April 2023 at 11:00am
|
|
Change of Director's Interest Notice
|
21 April 2023 at 7:05pm
|
|
Notification of cessation of securities - OIL
|
21 April 2023 at 6:55pm
|
|
Optiscan Establishes US Commercial Operation in Minnesota
|
3 April 2023 at 10:30am
|
|
Change of Director's Interest Notice - K Borg
|
31 March 2023 at 8:25pm
|
|
Change of Director's Interest Notice - R Cooke
|
30 March 2023 at 8:40am
|
|
Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
|
14 March 2023 at 8:50am
|
|
Optiscan Intends to pursue De Novo Pathway for InVivage
|
2 March 2023 at 12:55pm
|
|
OIL Appendix 4D and 31 December 2022 Half-year report
|
27 February 2023 at 1:20pm
|
|
Optiscan partners with Prolucid to develop AI Algorithms
|
30 January 2023 at 9:15am
|
|
OIL December 2022 Quarterly Report and Appendix 4C
|
27 January 2023 at 3:50pm
|
|
Section 708A Cleansing Notice
|
11 January 2023 at 7:20pm
|
|
Application for quotation of securities - OIL
|
11 January 2023 at 7:15pm
|
|
Change of Director's Interest Notice
|
12 December 2022 at 5:30pm
|
|
Section 708A Cleansing Notice
|
8 December 2022 at 5:40pm
|
|
Application for quotation of securities - OIL
|
8 December 2022 at 5:10pm
|
|
Application for quotation of securities - OIL
|
8 December 2022 at 5:10pm
|
|
Application for quotation of securities - OIL
|
8 December 2022 at 5:10pm
|
|
Amended Company Constitution
|
25 November 2022 at 1:35pm
|
|
Results of Annual General Meeting
|
24 November 2022 at 3:40pm
|
|
Optiscan Managing Director 2022 AGM Presentation
|
24 November 2022 at 11:20am
|
|
Optiscan Chairman's AGM Address
|
24 November 2022 at 11:20am
|
|
Statement pursuant to Listing Rule 4.7C.3
|
4 November 2022 at 11:20am
|
|
OIL September 2022 Quarterly Report and Appendix 4C
|
31 October 2022 at 2:10pm
|
|
2022 AGM - Letter to Shareholders & Proxy Form
|
25 October 2022 at 6:55pm
|
|
Notice of Annual General Meeting/Proxy Form
|
25 October 2022 at 6:45pm
|
|
Proposed issue of securities - OIL
|
25 October 2022 at 9:20am
|
|
Optiscan Imaging Acquires Intellectual Property
|
25 October 2022 at 9:20am
|
|
Optiscan receives R&D tax incentive rebate
|
24 October 2022 at 9:55am
|
|
Annual General Meeting Date
|
6 October 2022 at 5:20pm
|
|
Appendix 4G & Corporate Governance Statement
|
31 August 2022 at 7:15pm
|
|
Appendix 4E and 2022 Annual Report
|
31 August 2022 at 7:05pm
|
|
Optiscan Submits FDA 510(k) Application for InVivage Device
|
22 August 2022 at 9:55am
|
|
OIL June 2022 Quarterly Report and Appendix 4C
|
29 July 2022 at 3:20pm
|
|
Change in substantial holding
|
28 July 2022 at 2:25pm
|
|
Notification of cessation of securities - OIL
|
14 July 2022 at 3:15pm
|
|
Section 708A Cleansing Notice
|
1 July 2022 at 4:50pm
|
Optiscan Imaging